TRANQ Research Act of 2023

Dec 19, 2023
Dec 19, 2023

Summary

Directs a national science agency to research new dangerous drugs like xylazine and find better ways to detect and analyze them to protect public health.

What problem does this solve?

New dangerous drugs like xylazine, a tranquilizer, are being mixed with opioids, making them harder to detect and more deadly. This law directs the government's top science agency to develop new tools and methods to quickly identify these substances.

Who does this affect?

  • Public health officials
  • Law enforcement agencies
  • Scientific researchers and laboratories

What does this law do?

Directs research on new drugs
Requires the National Institute of Standards and Technology (NIST) to research and develop new ways to identify and understand substances containing xylazine and other new synthetic drugs.
Mandates a government capability study
Orders the Comptroller General to study how well the federal government can respond to threats from new psychoactive drugs like xylazine.
Promotes collaboration between agencies
Requires NIST to work with the DEA, CDC, and other federal, state, and private groups to create strategies for handling and analyzing new dangerous drugs.
Supports faster drug detection
Funds activities to help create technology that can identify xylazine and other new drugs in near-real time.
Encourages academic research
Pushes for graduate and post-graduate university programs to include the study of detecting and identifying xylazine and other new drugs.

What is the real world impact?

Improves public health and safety
Aims to give public health officials and first responders better tools to quickly identify new drug threats, which can help in treating overdoses and understanding emerging drug trends.
Strengthens law enforcement capabilities
Provides law enforcement agencies with advanced technology and methods to detect and analyze new illicit substances, helping them to better track and combat drug trafficking.

When does this start?

This law takes effect immediately and sets specific deadlines for reports to Congress.
NIST implementation report
The Director of NIST must submit a report to Congress on the progress of its research activities no later than one year after the law's enactment.
Comptroller general study report
The Comptroller General must report the findings of its study on the government's drug threat response capabilities to Congress within two years of the law's enactment.